Pet Recall Facts

Ingredients / Clotrimazole

Clotrimazole: FDA adverse event reports for pets

Reports received through June 26, 2026. Data and limitations.

8,104Total reports
7,026Dog reports
186Cat reports

FDA-approved products with this ingredient (Green Book)

All approved products with this ingredient, for any species.

Brand names come only from the Green Book. Brand names in FDA's public report data are masked, so counts cannot be attributed to any brand. Ingredient names in the reports are written many ways; we group them under one ingredient name and count each report once per ingredient (method).

Reports by year received

199344
199458
199546
199663
199780
199888
1999108
200071
200148
2002105
2003122
2004121
2005170
2006203
2007240
2008200
2009290
2010205
2011264
2012315
2013295
2014284
2015348
2016508
2017447
2018410
2019511
2020479
2021436
2022291
2023321
2024379
2025401
2026153

Species named in reports

Dog7,026
Not given860
Cat186
Human27
Other3
Guinea Pig1
Camel1

Signs reported after Clotrimazole

Deafness3,665
Partial deafness772
Temporary deafness510
Drug administration duration too long451
Loss of hearing433
PR-EAR(S), LESION(S)324
Vomiting258
Lack of efficacy - NOS228
Lethargy (see also Central nervous system depression in Neurological)227
Missing Cap222
Applicator, Abnormal210
Accidental exposure175
Overdose175
Incorrect dose administered NOS170
Underdose167
Diarrhoea154
Product problem136
Death by euthanasia129
Ataxia120
Anorexia117
Product Defect, General114
Behavioural disorder NOS111
Head tilt - ear disorder109
Depression107
Pinnal erythema100

Breeds named in reports

Crossbred Canine/dog968
Retriever - Labrador758
Retriever - Golden312
Terrier - Yorkshire304
Dog (unknown)281
Poodle (unspecified)246
Chihuahua239
Shepherd Dog - German234
Pug227
Boxer (German Boxer)211
Maltese204
Shih Tzu196
Pit Bull195
Terrier - West Highland White151
Bichon Frise122

Reported outcomes

Recovered with Sequela1,618
Ongoing1,098
Recovered/Normal992
Outcome Unknown903
Died117
Euthanized92

Report a problem to FDA